Please assess the completion status of the following clinical trial:

Trial Title: The Efficacy and Safety of Curcuma Domestica Extracts and Ibuprofen in Knee Osteoarthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Primary osteoarthritis~* Knee pain score more than or equal to 5 point (NRS 0-10)~* Age \>= 50 years, not \> 75 years~* Knee crepitus~* Knee stiffness less than 30 minutes~* Urine pregnancy test negative in case of not being menopausal period~Exclusion Criteria:~* History of GI ulcer or melena~* Having hepatic or bile duct diseases(SGOT ≥ 37 u/L, SGPT ≥ 40 u/L)~* Having renal disease or abnormal renal functions (serum creatinine ≥ 1.5 mg/dl)~* Asthma or gout~* Allergy to ibuprofen or curcumin~* History of intraarticular knee injection within 6 months~* Post knee arthroplasty~* History of intermittent claudication~* Unable to walk, for example hemiplegia, severe lung/heart diseases~* Knee x-ray found chondrocalcinosis~* On anticoagulant

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- curcuma domestica (Type: EXPERIMENTAL): 1,500 mg/day (oral) divided into 3 times for 28 days
- Ibuprofen (Type: ACTIVE_COMPARATOR): 1,200 mg/day (oral) divided into 3 times for 28 days

Based on this trial design, predict the completion outcome and termination type (if applicable).